These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 3488702)
1. Methylene blue decreases the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage. Richter AM; Abboud RT; Johal SS Am Rev Respir Dis; 1986 Aug; 134(2):326-7. PubMed ID: 3488702 [TBL] [Abstract][Full Text] [Related]
2. Acute effect of nitrogen dioxide exposure on the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage fluid of normal subjects. Mohsenin V; Gee JB Am Rev Respir Dis; 1987 Sep; 136(3):646-50. PubMed ID: 3498415 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. Cochrane CG; Spragg R; Revak SD J Clin Invest; 1983 Mar; 71(3):754-61. PubMed ID: 6600748 [TBL] [Abstract][Full Text] [Related]
4. Acute effect of smoking on the functional activity of alpha1-protease inhibitor in bronchoalveolar lavage fluid. Abboud RT; Fera T; Richter A; Tabona MZ; Johal S Am Rev Respir Dis; 1985 Jan; 131(1):79-85. PubMed ID: 3871315 [TBL] [Abstract][Full Text] [Related]
6. Quantitation of bronchoalveolar lavage with methylene blue. Baughman RP; Bosken CH; Loudon RG; Hurtubise P; Wesseler T Am Rev Respir Dis; 1983 Aug; 128(2):266-70. PubMed ID: 6881688 [TBL] [Abstract][Full Text] [Related]
7. The intrapulmonary half-life and safety of aerosolized alpha1-protease inhibitor in normal volunteers. Vogelmeier C; Kirlath I; Warrington S; Banik N; Ulbrich E; Du Bois RM Am J Respir Crit Care Med; 1997 Feb; 155(2):536-41. PubMed ID: 9032191 [TBL] [Abstract][Full Text] [Related]
11. Quantitation of bronchoalveolar lavage with methylene blue. Tuomanen E; Hill R Am Rev Respir Dis; 1984 Jul; 130(1):146-7. PubMed ID: 6742603 [No Abstract] [Full Text] [Related]
12. The antielastase screen of the lower respiratory tract. Bieth JG Eur J Respir Dis Suppl; 1985; 139():57-61. PubMed ID: 3876235 [TBL] [Abstract][Full Text] [Related]
13. Controversy about alpha 1-antitrypsin in bronchoalveolar lavage fluids. Stockley RA; Burnett D Lancet; 1983 Dec; 2(8362):1311. PubMed ID: 6139655 [No Abstract] [Full Text] [Related]
14. The effect of reducing agents on proteolytic enzymes and oxidation of alpha 1-proteinase inhibitor. Morrison HM; Burnett D; Stockley RA Biol Chem Hoppe Seyler; 1986 Mar; 367(3):177-82. PubMed ID: 3518737 [TBL] [Abstract][Full Text] [Related]
15. Alpha-1-antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects. Olsen GN; Harris JO; Castle JR; Waldman RH; Karmgard HJ J Clin Invest; 1975 Feb; 55(2):427-30. PubMed ID: 1079211 [TBL] [Abstract][Full Text] [Related]
16. Alpha-2-macroglobulin, monomeric and polymeric immunoglobulin A, and immunoglobulin M in bronchoalveolar lavage. Delacroix DL; Marchandise FX; Francis C; Sibille Y Am Rev Respir Dis; 1985 Oct; 132(4):829-35. PubMed ID: 2413791 [TBL] [Abstract][Full Text] [Related]